Vendor, Sarasota, FL, part of Proimmune Inc.
Proimmune, Inc.
UEI C97DJ9NYBGV9, CAGE 4V3U8
2 awards and -$5,267 obligated between July 29, 2026 and August 25, 2026, 0% under full and open competition, against 1.5 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Food and Drug Administration | -$1 |
| National Institutes of Health | -$5,266 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$1 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | -$5,266 |
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Not Competed Under SAP | 1 |
| Small Business Set Aside - Total | 1 |
| Purchase Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40121P00423Purchase Order, July 29, 2026, Competed Under SAP, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Purpose of This Modification Is to De-Obligate Excess Funds and Close Out the Contract.NAICS 541714, PSC AJ12 | -$1 |
| 75N93021P00656Purchase Order, August 25, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541990, PSC 6505 | -$5,266 |
- Product and service codes
- AJ12 General Science And Technology R&D Services; General Science And Technology; Applied Research6505 Drugs and Biologicals
- Transactions
- 2 across 2 awards